Jane Street Group LLC Has $770,000 Stock Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

Jane Street Group LLC decreased its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 7.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,405 shares of the company’s stock after selling 2,243 shares during the quarter. Jane Street Group LLC’s holdings in OrthoPediatrics were worth $770,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of KIDS. Wellington Management Group LLP grew its stake in OrthoPediatrics by 16.2% during the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock valued at $23,944,000 after acquiring an additional 122,846 shares in the last quarter. State Street Corp boosted its holdings in shares of OrthoPediatrics by 1.0% during the third quarter. State Street Corp now owns 417,898 shares of the company’s stock worth $11,329,000 after purchasing an additional 4,236 shares during the period. Quarry LP purchased a new position in OrthoPediatrics during the third quarter valued at approximately $25,000. Polar Asset Management Partners Inc. acquired a new position in OrthoPediatrics in the 3rd quarter valued at approximately $2,288,000. Finally, Portolan Capital Management LLC lifted its position in OrthoPediatrics by 66.2% in the 3rd quarter. Portolan Capital Management LLC now owns 308,099 shares of the company’s stock worth $8,353,000 after buying an additional 122,770 shares in the last quarter. 69.05% of the stock is owned by institutional investors and hedge funds.

OrthoPediatrics Stock Down 1.3 %

OrthoPediatrics stock opened at $22.87 on Friday. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. OrthoPediatrics Corp. has a 1-year low of $21.02 and a 1-year high of $35.99. The firm’s fifty day simple moving average is $24.58 and its 200-day simple moving average is $27.67. The company has a market capitalization of $553.82 million, a P/E ratio of -18.59 and a beta of 1.14.

Analyst Ratings Changes

Several equities analysts have recently commented on KIDS shares. JMP Securities restated a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a report on Friday, September 13th. Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a research note on Friday, November 8th. Finally, Truist Financial cut their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.